Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell cancer (ESCC) patients with the potentially resectable disease most would experience relapse after surgery. Immunotherapy has been reported to improve the prognosis of advanced esophageal cancer and may be a new strategy to prevent this urgent condition’s recurre...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Thorac Dis
Huvudupphovsmän: Wu, Zhigang, Zheng, Qiang, Chen, Haiquan, Xiang, Jiaqing, Hu, Hong, Li, Hang, Pan, Yunjian, Peng, Yizhou, Yao, Xingxin, Liu, Pengcheng, Sun, Yihua, Li, Bin, Zhang, Yawei
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2021
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264718/
https://ncbi.nlm.nih.gov/pubmed/34277047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-21-340
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk